Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L'Afrique Aide L'Afrique (AAA) is a Senegalese social enterprise and manufacturing initiative established by the Institut Pasteur de Dakar to enhance diagnostic autonomy across the African continent. The company focuses on the development and large-scale production of affordable, high-quality rapid diagnostic tests (RDTs) for a variety of infectious diseases, including COVID-19, yellow fever, and measles. Operating from a specialized facility in Dakar, AAA utilizes lateral flow technology to provide point-of-care solutions specifically designed for resource-limited settings. Through strategic partnerships with international organizations like Mologic and the Bill & Melinda Gates Foundation, the initiative aims to reduce Africa's reliance on imported medical supplies and strengthen local public health infrastructure. AAA represents a significant step toward regional self-sufficiency in medical diagnostics and pandemic preparedness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L’Afrique aide L’Afrique.